Castle Biosciences(US:CSTL) Globenewswireยท2025-09-17 11:00Core Insights - Castle Biosciences, Inc. has been recognized in Newsweek's inaugural 2025 America's Greatest Companies list, highlighting its strong performance in financial strength, workforce dedication, innovation, and commitment to environmental sustainability and corporate ethics [1][2] Company Overview - Castle Biosciences is a leading diagnostics company focused on improving health through innovative tests that guide patient care, with a mission to prioritize patients, clinicians, employees, and investors [3] Product Portfolio - The company's current portfolio includes tests for skin cancers, Barrett's esophagus, and uveal melanoma, along with ongoing research and development programs for additional tests addressing high clinical needs, such as a test for guiding systemic therapy selection in patients with moderate-to-severe atopic dermatitis [4]